Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
67692292 | 6769229 | 2 | F | 2000 | 20160624 | 20080924 | 20160705 | EXP | GB-002147023-PHBS2008GB05499 | GB-BAUSCH-2008BL003952 | BAUSCH AND LOMB | STUMPF T, AUSTIN M, BLOOM P, MCNAUGHT A, MORGAN J. TRANSCLERAL CYCLODIODE LASER PHOTOCOAGULATION IN THE TREATMENT OF AQUEOUS MISDIRECTION SYNDROME. OPHTHALMOLOGY. 2008;115:2058-2061. | 25.00 | YR | M | Y | 0.00000 | 20160705 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
67692292 | 6769229 | 1 | PS | TIMOLOL MALEATE. | TIMOLOL MALEATE | 1 | Ophthalmic | U | 74776 | EYE DROPS | |||||||||
67692292 | 6769229 | 2 | SS | PILOCARPINE. | PILOCARPINE | 1 | Ophthalmic | U | 999999 | EYE DROPS | |||||||||
67692292 | 6769229 | 3 | SS | ATROPINE. | ATROPINE | 1 | Ophthalmic | U | 999999 | EYE DROPS | |||||||||
67692292 | 6769229 | 4 | SS | ATROPINE. | ATROPINE | 1 | U | 999999 | |||||||||||
67692292 | 6769229 | 5 | SS | ATROPINE. | ATROPINE | 1 | U | 999999 | |||||||||||
67692292 | 6769229 | 6 | SS | DORZOLAMIDE HYDROCHLORIDE. | DORZOLAMIDE HYDROCHLORIDE | 1 | Ophthalmic | U | 90143 | EYE DROPS | |||||||||
67692292 | 6769229 | 7 | SS | LATANOPROST. | LATANOPROST | 1 | Ophthalmic | U | 201006 | EYE DROPS | |||||||||
67692292 | 6769229 | 8 | SS | ACETAZOLAMIDE. | ACETAZOLAMIDE | 1 | Oral | U | 0 | ||||||||||
67692292 | 6769229 | 9 | SS | ACETAZOLAMIDE. | ACETAZOLAMIDE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
67692292 | 6769229 | 1 | Intraocular pressure increased |
67692292 | 6769229 | 2 | Intraocular pressure increased |
67692292 | 6769229 | 3 | Cycloplegia |
67692292 | 6769229 | 4 | Eye inflammation |
67692292 | 6769229 | 5 | Anterior chamber disorder |
67692292 | 6769229 | 6 | Intraocular pressure increased |
67692292 | 6769229 | 7 | Intraocular pressure increased |
67692292 | 6769229 | 8 | Intraocular pressure increased |
67692292 | 6769229 | 9 | Anterior chamber disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
67692292 | 6769229 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
67692292 | 6769229 | Anterior chamber disorder | |
67692292 | 6769229 | Drug ineffective | |
67692292 | 6769229 | Hyphaema | |
67692292 | 6769229 | Intraocular pressure increased | |
67692292 | 6769229 | Iridocyclitis | |
67692292 | 6769229 | Product quality issue | |
67692292 | 6769229 | Visual acuity tests abnormal | |
67692292 | 6769229 | Visual field defect |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
67692292 | 6769229 | 1 | 2000 | 0 | ||
67692292 | 6769229 | 2 | 2000 | 0 | ||
67692292 | 6769229 | 6 | 2000 | 0 | ||
67692292 | 6769229 | 7 | 2000 | 0 |